Effects of theophylline on respiratory drive in patients with chronic obstructive pulmonary disease

Journal of Clinical Pharmacology

Volumn 37, Issue 12, 1997, Pages 1100-1107

  Ashutosh, Kumar ^a   Sedat, Mohammad ^a   Fragale Jackson, Jody ^a  

^a SYRACUSE VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CARBON DIOXIDE; IPRATROPIUM BROMIDE; OXYGEN; PLACEBO; THEOPHYLLINE;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; END TIDAL CARBON DIOXIDE TENSION; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG MINUTE VOLUME; MALE; MOUTH OCCLUSION PRESSURE; ORAL DRUG ADMINISTRATION; OXYGEN CONSUMPTION; REBREATHING; RESPIRATORY DRIVE; THEOPHYLLINE BLOOD LEVEL;

EID: 0031424276     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1997.tb04293.x     Document Type: Article

References (25)

1. Milgrom H, Bender B: Current issues in the use of theophylline. Am Rev Respir Dis 1993;147:S33-S39.
2. Newhouse MT: Is theophylline obsolete? Chest 1990; 98:1-3.
3. Murciano D, Aubier M, Lecocguic Y, Pariente R: Effects of theophyllino on diaphragmatic strength and fatigue in patients with chronic obstructive pulmonary disease. N Engl J Med 1984:311:349-353.
4. Marsh GD, McFadden RG, Nicholoson RL, Leasa DJ, Thomson RT: Theophylline delays skeletal muscle fatigue during progressive exercise. Am Rev Respir Dis 1993:147:876-879.
5. Bertolet BD, McMurtrie EB, Hill JA, Belardinelli L: Theophylline for the treatment of atrioventricular block after myocardial infarction. Ann Intern Med 1995:123:509-511.
6. G. Parker JO, Ashekian PB, DiGiorgi S, West RO: Hemodynamic effects of aminophylline in COPD. Circulation 1967:35:65-72.
7. Ziment I: Phosphodiesterase inhibitors in Respiratory Pharmacology and Therapeutics. Philadelphia: WB Saunders, 1978.
8. Ward AJM, McKennif M, Evans J, Page CP, Costello JF: Theophylline an immunomodulary role in asthma. Am Rev Respir Dis 1993:147:518-523.
9. Swaminathan S, Paton JY, Davidson, Ward SL, Sargeant CW, Keens TG: Theophylline does not increase ventilatory response to hypercapnia or hypoxia. Am Rev Respir Dis 1993:146:1398-1402.
10. Umut S, Gemicioglu B, Yildirim N, Barlas A, Ozuner Z: Effect of theophylline in chronic obstructive lung disease. Int f Pharmacol Ther Toxicol 1992:30:149-152.
11. Sanders JS, Berman TM, Bartlet MM, Krorenberg RS: Increased hypoxic ventilatory drive due to administration of aminophylline in normal men. Chest 1980:78:279-282.
12. Fitzpatrick MF, Engleman HM, Boellert F, McHardy R, Shapiro CM, Deary IJ, Douglas NJ: Effect of theophylline levels on sleep quality and daytime performance of normal subjects. Am Rev Respir Dis 1992:145:1355-1358.
13. Espinoza H, Antic R, Thomson AT, McEvoy RD: Effect of aminophylline on sleep and sleep disordered breathing in patients \vith obstructive sleep apnea syndrome. Am Rev Respir Dis 1987:136:80-84.
14. Murciano D, Auclair MH, Pariento R, Aubier M: Theophylline in severe COPD. N Engl] Med 1989;320:1521-1525.
15. Sharp JT: Theophylline in COPD. J Allerg Clin Immunol 1987;78:800-805.
16. Whitelaw W, Derenne J. Miller-Emili J: Occlusion pressure as a measure of respiratory center output in conscious man. Respir physiol 1975;23:181-199.
17. Verma R, Dewan M, Ashutosh K: Respiratory sensitivity to carbon dioxide in schizophrenia. Respiration 1987:52:34-41.
18. Eldridge FL: Post hyperventilation breathing: different effects of active and passive hyperventilation. J Appl Physiol 1973:34:422-430.
19. Altose MD, Kelsen SG, Stanley NN, Levinson PS, Cherinak NS, Fishman A: Effects of hypercapnia on mouth pressure during airway occlusion in conscious man. J Appl Physiol 1976;40:338-344.
20. Spinelli A, Fanelli A, Gorini M, Sanna A, Francois C, Scano G: Control of breathing in patients with COPD: response to bamiphylline. Respiration 1993;58:241-248.
21. Ashutosh K, Bajaj R, Cho C, Saugain G: Use of serum theophylline level as a guide to optimum therapy in patients with chronic obstructive pulmonary disease. J Clin Pharmacol 1990;30:324-329.
22. Ashutosh K, Dev G, Steele D: Nonbronchodilator effects of pirbuterol and ipratropium in COPD. Chest 1995;107:173-179.
23. Lagercrantz H, Yamanoto X, Fredham BA, Prabhakar NR, Von Euler C: Adenosine analogues depress ventilation in rabbit neonates: thcophylline stimulation of respiration via adenosine receptors. PediatrRes 1984; 18:387-390.
24. Yamaoto Y, Lagercrantz H, Fredholm BB, VonEulor C: Effects of some neuromuscular substances on ventilation in new born rabbits. Ada Physiol Scand 1982;508(suppl):34.
25. Jolley ME, Stroupe SD, Schwenzer KS, Wang CJ, Lu Stoffes M, Hill HD, et al: Fluorocence polarization immunoassay III anantomated system for therapeutic drug determination. Clin Chem 1981:27:1575-1579.